academic article

• Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease..  Science (New York, N.Y.).  317:516-9. 2007
• Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models..  Biochemical and biophysical research communications.  357:596-602. 2007